B-cell depleting therapies may affect susceptibility to acute respiratory illness among patients with Multiple Sclerosis during the early COVID-19 epidemic in Iran (Q94673106)
Jump to navigation
Jump to search
scientific article published on 13 May 2020
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | B-cell depleting therapies may affect susceptibility to acute respiratory illness among patients with Multiple Sclerosis during the early COVID-19 epidemic in Iran |
scientific article published on 13 May 2020 |
Statements
B-cell depleting therapies may affect susceptibility to acute respiratory illness among patients with Multiple Sclerosis during the early COVID-19 epidemic in Iran (English)
Farinaz Safavi
Bardia Nourbakhsh